CCRM Nordic Welcomes Lars-Johan Cederbrant to Its Board of Directors
CCRM Nordic is pleased to announce the appointment of Lars-Johan Cederbrant to its Board of Directors. Lars-Johan currently serves as Chief Financial Officer (CFO) of AstraZeneca AB, the Swedish Hub of AstraZeneca, and is a member of AstraZeneca’s global Finance Senior Management Team and Sweden Leadership Team.
With a distinguished career spanning leadership roles across AstraZeneca’s corporate finance functions globally, Lars-Johan brings deep expertise in biopharma finance and strategic development. His prior experience also includes CFO positions outside AstraZeneca, such as serving as CFO for a company listed on NASDAQ Stockholm, as well as working as a management consultant.
“I’ve been working in the field of life science for a long time, and I very much look forward to supporting CCRM Nordic in their endeavour to build a leading hub and to support the commercialization of ATMPs,” said Lars-Johan Cederbrant.
CCRM Nordic’s collaborative consortium model thrives on the contributions of industry leaders who bring broad perspectives and powerful networks to the table. With the addition of Lars-Johan Cederbrant, CCRM Nordic further strengthens its ability to advance capabilities and deliver impact in the rapidly evolving ATMP landscape.
“We’re confident that Lars-Johan’s deep experience in the biopharma world and strong financial expertise will be a huge asset as we continue to grow and support innovation in the ATMP space,” said Jan Nilsson, Chairman of the Board at CCRM Nordic. “We all look forward to what lies ahead with him on the team.”